Avui, dilluns 8 de juny, el Dipòsit Digital no estarà operatiu de 15:00 a 17:00 h per tasques de manteniment. Disculpeu les molèsties.
Hoy, lunes 8 de junio, el Dipòsit Digital no estará operativo de 15:00 a 17:00 h debido a tareas de mantenimiento. Disculpen las molestias.
Today, Monday, Jun 8th, the Digital Repository will be unavailable due to a system update.

Document type

Book part

Version

Published version

Publication date

All rights reserved

Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/21371

Inhibitors of the M2 channel of influenza A virus

Journal Title

Director/Tutor

Journal ISSN

Volume Title

Abstract

Influenza is a highly contagious, major respiratory tract disease affecting millions of people each year. At present, two classes of antivirals are available: the neuraminidase inhibitors and the M2 proton channel blockers amantadine and rimantadine. However, rapid emergence of M2 blockers resistance makes imperative the development of new anti-influenza drugs. In the last few years several groups have synthesized and evaluated several analogs of amantadine. While several of them are active against wild-type M2 channel only a few are able to inhibit the mutant ion channels that lead to amantadine-resistance.

Description

Podeu consultar el llibre complet a: http://hdl.handle.net/2445/32392

Citation

Citation

DUQUE, María D., et al. Inhibitors of the M2 channel of influenza A virus. Recent Advances in Pharmaceutical Sciences. 2011. Vol.  Chapter 2, num. 35-64. [consulted: 9 of June of 2026]. Available at: https://hdl.handle.net/2445/21371

Export metadata

JSON - METS

Share record